This inventor holds 8 USPTO granted patents and 17 published patent applications, plus 2 CIPO patents and 5 EPO patents. Top assignees: Cyclerion Therapeutics, Inc., Bionomics Inc., Ironwood Pharmaceuticals, Inc.. Active years: 2017-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Cambridge, MA (US) (2017 - 2022)
- Southborough, MA (US) (2021 - 2024)
Company Filing History:
6 out of 25 
2 out of 64 
2 out of 44 
Years Active: 2017-2025
Title: The Innovative Mind of Ahmad Hashash: Pioneering Advances in Soluble Guanylate Cyclase Stimulation
Introduction
Ahmad Hashash is a prominent inventor based in Cambridge, MA, who has made significant contributions to the field of pharmaceutical sciences. With a portfolio of seven patents, he has focused on developing novel processes and compounds that enhance the efficacy of soluble guanylate cyclase stimulators, which hold therapeutic potential in various medical applications.
Latest Patents
One of Ahmad Hashash's latest patents revolves around "Processes and intermediates for the preparation of soluble guanylate cyclase stimulators." This invention details innovative processes for synthesizing compounds that serve as stimulators of soluble guanylate cyclase (sGC). The compounds produced through these processes include stable 3-(2-pyrimidinyl)pyrazoles of Formula I, characterized by high purity and yield. The invention offers substantial advantages, including simplified reaction conditions that facilitate large-scale manufacturing. Moreover, it introduces novel intermediates essential for the preparation of these beneficial compounds.
Career Highlights
Throughout his career, Ahmad Hashash has worked with several notable organizations, including Cyclerion Therapeutics, Inc. and Bionomics Inc. His work in these companies has been instrumental in advancing research and development in the pharmaceutical sector, focusing on compounds that aim to address critical health issues.
Collaborations
Ahmad has collaborated with talented professionals in his field, such as Song Xue and Vasu Sethuraman. These collaborative efforts have resulted in significant advancements in their respective projects, contributing to the overall success of their research endeavors.
Conclusion
Ahmad Hashash's innovative spirit and dedication to research continue to drive advancements in soluble guanylate cyclase stimulation. His patented processes and compounds have the potential to make a substantial impact on the pharmaceutical industry, paving the way for new therapeutic options for patients in need. As he progresses in his career, the contributions of Ahmad Hashash will undoubtedly remain influential in the field of medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile